Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Otitis media with effusion (OME) is common and may cause hearing loss with associated developmental delay. Treatment remains controversial. OBJECTIVES: To examine evidence for or against treating children with hearing loss associated with OME with systemic or topical intranasal steroids. SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library Issue 4 2005, MEDLINE (1966 to 2006), EMBASE (1974 to 2006), and the CINAHL, LILACS, Zetoc, IndMED, SAMED, KoreaMed, MEDCARIB and Cambridge Scientific Abstracts databases in January 2006. SELECTION CRITERIA: Randomised controlled trials of oral and topical intranasal steroids, either alone or in combination with another agent such as an antibiotic, were included. EXCLUSIONS: publications in abstract form only; uncontrolled, non-randomised or retrospective studies; studies reporting outcomes with ears (rather than children). DATA COLLECTION AND ANALYSIS: Data were extracted from the published reports by the authors independently using standardised data extraction forms and methods. The methodological quality of the included studies was independently assessed by the authors as described in the Cochrane Handbook. Dichotomous results were expressed as an odds ratio using a fixed-effect model together with the 95% confidence intervals. Continuous data were analysed using the weighted mean difference in a fixed-effect model. Tests for heterogeneity between studies were performed using a Mantel-Haenszel approach. In trials with a cross-over design, post cross-over treatment data were not used. MAIN RESULTS: No study prospectively documented hearing loss associated with OME prior to randomisation. Follow up was mainly short term. The odds ratio for OME persisting after short-term follow up in children treated with oral steroids compared to control was 0.22 (95% CI 0.08 to 0.63). The odds ratio for OME persisting after short-term follow up for children treated with oral steroids plus antibiotic compared to control plus antibiotic was 0.37 (95% CI 0.25 to 0.56). However, there was significant heterogeneity between studies included in the latter comparison (P < 0.01). Trends favoured steroids for most other comparisons, but confidence intervals included unity. There was no evidence of benefit for steroid treatment for OME or hearing loss associated with OME in the longer term. AUTHORS' CONCLUSIONS: Both oral and topical intranasal steroids alone or in combination with an antibiotic lead to a quicker resolution of OME in the short term, however, there is no evidence of longer term benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Systemic steroid for chronic otitis media with effusion in children
Mandel, E. M., Casselbrant, M. L., Rockette, H. E., Fireman, P., Kurs-Lasky, M., & Bluestone, C. D. (2002) · Pediatrics · doi:10.1542/peds.110.6.1071 · Cited by 51
Oral dexamethasone for treatment of persistent middle ear effusion
Macknin, M. L., & Jones, P. K. (1985) · Pediatrics · doi:10.1542/peds.75.2.329 · Cited by 48
BERMAN, S., GROSE, K., NUSS, R., HUBER-NAVIN, C., ROARK, R., GABBARD, S. A., & BAGNALL, T. (1990) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199008000-00001 · Cited by 46
Oral steroid therapy for chronic middle ear perfusion: a double-blind crossover study
Lambert, P. R. (1986) · Otolaryngology–Head and Neck Surgery · doi:10.1177/019459988609500211 · Cited by 30
Cited by
Clinical Practice Guideline: Otitis Media with Effusion (Update)
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006
Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children
Browning, G. G., Rovers, M. M., Williamson, I., Lous, J., & Burton, M. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001801.pub3 · Cited by 448
Simpson, S. A., Lewis, R., van der Voort, J., & Butler, C. C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001935.pub3 · Cited by 184
Self-citationBruce, I., Harman, N., Williamson, P., Tierney, S., Callery, P., Mohiuddin, S., Payne, K., Fenwick, E., Kirkham, J., & O’Brien, K. (2015) · Health Technology Assessment · doi:10.3310/hta19680 · Cited by 65
Williamson, I., Benge, S., Barton, S., Petrou, S., Letley, L., Fasey, N., Haggard, M., & Little, P. (2009) · BMJ · doi:10.1136/bmj.b4984 · Cited by 57
Bagher Rahmati, M., Safdarian, F., Shiroui, B., Zare, S., & Sadeghi, N. (2017) · Electronic Physician · doi:10.19082/4890 · Cited by 5
“The results of trials on effectiveness of pharmacological treatments of OME are inconsistent (9-13).”
Background
Metadata
- Authors
- Thomas, C. L., Simpson, S. A., Butler, C. C., van der Voort, J., & Lewis, R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2006-07-19
- Issue
- 3
- Pages
- CD001935-CD001935
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4244672446
- Cited by
- 63
- References
- 5
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.